{"entity":{"type":"insider","cik":"0001745009","url":"/insider/0001745009","json_url":"/insider/0001745009.json","name":"Shire Human Genetic Therapies, Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2020-06-03","last":"2020-06-30","span_basis":"filed_date"},"name_variants":[{"name":"Shire Human Genetic Therapies, Inc.","source":"filing","n_filings":3,"first_seen":"2020-06-03","last_seen":"2020-06-30"}],"transactions":[{"id":3333301,"accession":"0001395064-20-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-20-000122","line_url":"/filing/0001395064-20-000122#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Translate Bio, Inc.","issuer_ticker":"TBIO","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":null,"owner_name":"TAKEDA PHARMACEUTICAL CO LTD; Shire Human Genetic Therapies, Inc.","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6824992.0,"shares_display":"6,824,992","price_per_share":20.68,"price_display":"20.68","price_state":"stated","total_value":141140834.56,"total_display":"141,140,834.56","total_whole":"141,140,835","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-06-30","scope":"insider"},{"id":2395997,"accession":"0001395064-20-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-20-000084","line_url":"/filing/0001395064-20-000084#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Translate Bio, Inc.","issuer_ticker":"TBIO","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":null,"owner_name":"Shire Human Genetic Therapies, Inc.; TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"Shire Human Genetic Therapies, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40086.0,"shares_display":"40,086","price_per_share":19.75,"price_display":"19.75","price_state":"stated","total_value":791698.5,"total_display":"791,698.50","total_whole":"791,699","shares_owned_after":6824992.0,"shares_owned_after_display":"6,824,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"},{"id":2906295,"accession":"0001395064-20-000082","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001395064-20-000082","line_url":"/filing/0001395064-20-000082","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Translate Bio, Inc.","issuer_ticker":"TBIO","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":null,"owner_name":"Shire Human Genetic Therapies, Inc.; TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"Shire Human Genetic Therapies, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105395.0,"shares_display":"105,395","price_per_share":19.76282432752977,"price_display":"19.76","price_state":"stated","total_value":2082902.87,"total_display":"2,082,902.87","total_whole":"2,082,903","shares_owned_after":6870084.0,"shares_owned_after_display":"6,870,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider","n_lines":2},{"id":2906289,"accession":"0001395064-20-000082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-20-000082","line_url":"/filing/0001395064-20-000082","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Translate Bio, Inc.","issuer_ticker":"TBIO","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":null,"owner_name":"Shire Human Genetic Therapies, Inc.; TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"Shire Human Genetic Therapies, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108472.0,"shares_display":"108,472","price_per_share":19.85877645844089,"price_display":"19.86","price_state":"stated","total_value":2154121.2,"total_display":"2,154,121.20","total_whole":"2,154,121","shares_owned_after":6971873.0,"shares_owned_after_display":"6,971,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001693415","name":"Translate Bio, Inc.","url":"/issuer/0001693415","role":"Ten percent owner","n_filings":3,"first_seen":"2020-06-03","last_seen":"2020-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001745009","retrieved_at":"2026-08-22T21:55:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}